Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acacia Pharma
Acacia Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Barhemsys
Amisulpride
2020-02-26
2031-2038
—
Byfavo
Remimazolam
2020-10-06
2027-2033
Conscious sedation
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Amisulpride
major depressive disorder
,
healthy volunteers/patients
,
gastrointestinal microbiome
,
anorexia
,
anorexia nervosa
,
psychological stress
,
obsessive-compulsive disorder
,
compulsive behavior
,
compulsive personality disorder
,
chronic kidney failure
,
therapeutic equivalency
,
bipolar disorder
,
intellectual disability
,
postoperative nausea and vomiting
,
vomiting
,
nausea
,
dementia
,
psychophysiologic disorders
,
anxiety disorders
,
somatoform disorders
,
sialorrhea
,
schizophrenia
,
psychotic disorders
,
depression
,
mental disorders
,
treatment-resistant schizophrenia
,
depressive disorder
,
schizophrenia spectrum and other psychotic disorders
,
alzheimer disease
,
tardive dyskinesia
,
dyskinesias
,
prodromal symptoms
,
metabolic syndrome
,
hyperprolactinemia
,
syndrome
,
chronic pain
,
myofascial pain syndromes
,
fibromyalgia
,
addictive behavior
,
treatment-resistant depressive disorder
,
diabetes mellitus
,
insulin resistance
,
microvascular angina
,
periodontal diseases
Enoblituzumab
crohn disease
Calcium dobesilate
healthy volunteers/patients
,
cataract
,
dry eye syndromes
,
cataract extraction
,
glaucoma
,
postoperative pain
,
vitreoretinal surgery
,
macular edema
,
retinal vein occlusion
,
macular degeneration
,
inflammation
,
retinal detachment
,
refractive surgical procedures
,
patient preference
,
graft vs host disease
,
keratoconus
,
pterygium
Lornoxicam
multiple myeloma
,
b-cell chronic lymphocytic leukemia
,
plasma cell neoplasms
,
hodgkin disease
,
neoplasms
,
breast neoplasms
,
lymphoma
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
inflammatory breast neoplasms
,
non-hodgkin lymphoma
,
mantle-cell lymphoma
,
carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
Bos taurus adrenal cortex corticosteroids
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
covid-19
,
macular edema
,
uveitis
,
lymphoma
,
atopic dermatitis
,
follicular lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
non-small-cell lung carcinoma
,
inflammation
,
ischemic optic neuropathy
,
bullous pemphigoid
,
non-hodgkin lymphoma
,
lung neoplasms
,
exanthema
,
lupus nephritis
,
nephritis
,
neuromyelitis optica
,
nasal polyps
,
systemic lupus erythematosus
,
breast neoplasms
,
myasthenia gravis
,
pemphigus
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
chronic progressive multiple sclerosis
,
sclerosis
,
end stage liver disease
,
asthma
,
kidney transplantation
,
rheumatoid arthritis
,
arthritis
,
giant cell arteritis
,
liver transplantation
,
juvenile arthritis
,
heart transplantation
,
kidney diseases
,
arteritis
,
polymyalgia rheumatica
,
hypersensitivity
Anthracycline
lung neoplasms
,
small cell lung carcinoma
APD209
keratoconjunctivitis
,
conjunctivitis
,
viral conjunctivitis
,
wasting syndrome
,
cachexia
Trinessa
postpartum hemorrhage
Fluoroquinolone
parkinson disease
,
healthy volunteers/patients
Isoxaflutole
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use